Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Monday's Intraday Session

 

Gainers

  • Genprex (NASDAQ:GNPX) stock moved upwards by 117.5% to $2.85 during Monday's regular session. Genprex's stock is trading at a volume of 101.5 million shares as of 12:30 EST. This is 22317.8% of its average full-day volume over the last 100 days. The company's market cap stands at $136.2 million.
  • Immix Biopharma (NASDAQ:IMMX) shares increased by 109.55% to $7.46. Trading volume for Immix Biopharma's stock is 115.1 million as of 12:30 EST. This is 9150.7% of its average full-day volume over the last 100 days. The company's market cap stands at $56.5 million.
  • Pear Therapeutics (NASDAQ:PEAR) stock increased by 25.32% to $7.77. As of 12:30 EST, Pear Therapeutics's stock is trading at a volume of 5.3 million, which is 1173.3% of its average full-day volume over the last 100 days. The company's market cap stands at $1.0 billion.
  • Unity Biotechnology (NASDAQ:UBX) shares increased by 17.8% to $1.72. As of 12:30 EST, Unity Biotechnology's stock is trading at a volume of 3.2 million, which is 336.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $99.2 million.
  • Exicure (NASDAQ:XCUR) stock rose 17.76% to $0.24. As of 12:30 EST, Exicure's stock is trading at a volume of 12.1 million, which is 514.7% of its average full-day volume over the last 100 days. The company's market cap stands at $24.0 million.
  • Organovo Holdings (NASDAQ:ONVO) shares moved upwards by 16.11% to $4.21. Organovo Holdings's stock is trading at a volume of 68.0K shares as of 12:30 EST. This is 109.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $36.6 million.
  •  

Losers

  • Applied Therapeutics (NASDAQ:APLT) stock declined by 32.4% to $6.05 during Monday's regular session. Applied Therapeutics's stock is trading at a volume of 4.8 million shares as of 12:30 EST. This is 5152.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $158.6 million.
  • Kiora Pharmaceuticals (NASDAQ:KPRX) shares decreased by 16.55% to $1.26. As of 12:30 EST, this security is trading at a volume of 3.7 million shares, making up 30.9% of its average full-day volume over the last 100 days. The company's market cap stands at $15.9 million.
  • Nutriband (NASDAQ:NTRB) shares decreased by 15.78% to $8.49. As of 12:30 EST, this security is trading at a volume of 7.2 million shares, making up 206.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $66.0 million.
  • Biofrontera (NASDAQ:BFRI) stock declined by 13.3% to $6.52. The current volume of 3.3 million shares is 11.5% of Biofrontera's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $98.1 million.
  • Galera Therapeutics (NASDAQ:GRTX) stock declined by 11.79% to $4.05. Trading volume for this security as of 12:30 EST is 2.6 million, which is 21.5% of its average full-day volume over the last 100 days. The company's market cap stands at $107.0 million.
  • Spero Therapeutics (NASDAQ:SPRO) stock decreased by 11.5% to $14.17. Trading volume for Spero Therapeutics's stock is 115.8K as of 12:30 EST. This is 116.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $458.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.